hot line:010-83057670
en
about
about us
stock(600222)
leadingpharm (stock code 600222) was established in 2005 and is a high-quality supplier providing full industry chain services such as pharmaceutical cmc, clinical cro, and mah to the world. the company has a senior r&d management team of over a thousand people, a comprehensive drug r&d quality management system, and rich project experience, providing customers with customized solutions throughout the entire process from product approval to commercial transformation.
service
services
solution
dedicated to providing customers with integrated solutions for pharmaceutical r&d, clinical research and mah
- shenyang
- dalian
- hangzhou
- beijing
- shijiazhuang
- zhengzhou
- wuhan
- changsha
- guangzhou
- taiyuan
- lanzhou
- xian
- tianjin
news
news
- company news
-
in-depth interview | the "deep blue ocean" force in the cro field of cell and gene therapy (cgt)
2025-09-15 -
pooling strengths of industry-academia-research-application, promoting development driven by innovation | the 5th four-party party building event & commemoration of the 80th anniversary of the victory of the anti-japanese war successfully held
2025-08-11 -
world's first! leadingpharm cxo · deep blue ocean bio-pharmaceutical assists clinical research of non-viral vector gene therapy for dmd, opening a new paradigm in gene therapy!
2025-07-15
010-83057670
address：
marketing department：
leadingpharm
pharm news
010-61006450
